Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 2/20 | 0.34 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17081270 | 0.87 | ABCG2 (0.31) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL18383250 | 0.83 | ALOX5 (0.41) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL17081285 | 0.81 | ALOX5 (0.50) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL12206336 | 0.81 | ALOX5 (0.43) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL12206320 | 0.81 | ALOX5 (0.44) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL17081240 | 0.80 | ALOX5 (0.40) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL16596207 | 0.80 | ALOX5 (0.42) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL18383253 | 0.80 | CA12 (0.34) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL24658098 | 0.79 | ALOX5 (0.41) | CDC14BCDC14AALOX5PTGES2GGPS1 | |
| SCHEMBL18164852 | 0.79 | ALOX5 (0.39) | CDC14BCDC14AALOX5PTGES2GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3114102-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-12-06 | — | — | EP | disclosed |
| US-20170018710-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-01-19 | — | — | US | disclosed |
| US-20170018710-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-01-19 | — | — | US | disclosed |
| WO-2015131976-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170018710-A1 | MATERIALS FOR ELECTRONIC DEVICES | EED, OCIAD2, JUND | CDC14B 4343/4885CDC14A 3814/4885ALOX5 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.